Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | DOT1-like histone H3K79 methyltransferase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | histone h3 methyltransferase | Get druggable targets OG5_130680 | All targets in OG5_130680 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_130680 | All targets in OG5_130680 |
Schistosoma mansoni | histone J3 methyltransferase | Get druggable targets OG5_130680 | All targets in OG5_130680 |
Brugia malayi | Histone-lysine N-methyltransferase, H3 lysine-79 specific | Get druggable targets OG5_130680 | All targets in OG5_130680 |
Schistosoma japonicum | ko:K05302 histone-lysine N-methyltransferase [EC2.1.1.43], putative | Get druggable targets OG5_130680 | All targets in OG5_130680 |
Echinococcus granulosus | histone h3 methyltransferase | Get druggable targets OG5_130680 | All targets in OG5_130680 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | importin beta-1 subunit, putative | 0.002 | 0 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.171 | 0.1548 |
Plasmodium vivax | importin-beta 2, putative | 0.0025 | 0.0192 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.171 | 0.1548 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.171 | 0.1548 |
Trypanosoma cruzi | importin beta-1 subunit, putative | 0.002 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.5512 | 0.5424 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0025 | 0.0192 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.171 | 0.1548 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.171 | 0.1548 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.002 | 0 | 0.5 |
Trichomonas vaginalis | importin beta-1, putative | 0.002 | 0 | 0.5 |
Brugia malayi | RNA binding protein | 0.0062 | 0.171 | 0.2854 |
Toxoplasma gondii | HEAT repeat-containing protein | 0.0025 | 0.0192 | 0.5 |
Echinococcus multilocularis | snurportin 1 | 0.0265 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.171 | 0.2854 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.171 | 0.2854 |
Plasmodium falciparum | importin beta, putative | 0.0025 | 0.0192 | 0.5 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0265 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.002 | 0 | 0.5 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0025 | 0.0192 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.171 | 0.1548 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.171 | 0.1548 |
Echinococcus multilocularis | histone h3 methyltransferase | 0.0155 | 0.5512 | 0.5424 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.171 | 0.1548 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.002 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.171 | 0.1548 |
Brugia malayi | RNA, U transporter 1 | 0.0071 | 0.2061 | 0.3513 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.171 | 0.1548 |
Schistosoma mansoni | hypothetical protein | 0.0265 | 1 | 1 |
Echinococcus granulosus | histone h3 methyltransferase | 0.0155 | 0.5512 | 0.5424 |
Schistosoma mansoni | histone J3 methyltransferase | 0.0155 | 0.5512 | 0.5424 |
Brugia malayi | Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0.0155 | 0.5512 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.08 uM | Inhibition of human recombinant DOT1L catalytic domain amino acid (1 to 472) using [3H]-SAM after 30 mins by scintillation counter | ChEMBL. | 22924785 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.